Tiger Mosquito Invasions Now Trigger European Outbreaks in Under Five Years — Down from 25

By David Ogilvy, Chief Marketing Officer at Mosticare Global | Published 2026-05-13

When the Asian tiger mosquito (Aedes albopictus) first appeared in Belgium in 2008, European health authorities had no immediate cause for alarm. History suggested the lag before any locally transmitted disease would be long. In Italy, where the mosquito established itself in the mid-1990s, the first autochthonous chikungunya outbreak did not arrive until 2007 — more than a decade later. That gap — roughly 25 years on average across early European invasions — was reassuring. It seemed to suggest that newly colonised countries had time to prepare.

That 25-year buffer no longer exists.

A time-to-event analysis published in The Lancet Regional Health – Europe, covering European tiger mosquito invasions from 1990 to 2024, has tracked how long it takes for a newly established Aedes albopictus population to produce its first locally transmitted dengue or chikungunya outbreak. The finding: the median delay has collapsed from 25 years in early invasions to under 5 years in recent ones. The interval between successive outbreaks in countries already affected has fallen from roughly 12 years to under one.

Four Numbers That Reframe European Vector Risk

The analysis yields two pairs of figures, each telling the same story from a different angle.

The first pair describes the time to initial outbreak: 25 years, then less than 5. The second pair describes recurrence: approximately 12 years between outbreaks, now less than 1.

These are medians across diverse national contexts. They do not mean every new invasion will produce an outbreak within five years. They mean that the assumption of a long incubation period between arrival and impact — an assumption that shaped European surveillance design for two decades — is now empirically false.

The mechanism behind the acceleration is not mysterious. Aedes albopictus populations are larger, denser, and more widely distributed than in previous decades. The climate envelope that allows viral replication within the mosquito — the extrinsic incubation period — now opens earlier in spring and closes later in autumn. Travel volumes have recovered fully from the pandemic, maintaining a steady flow of viraemic passengers into cities where biting mosquitoes are waiting. And in regions where the mosquito has been present for years, local adaptation may have produced populations better suited to temperate conditions.

Each of these factors compounds the others. Together, they produce invasion dynamics with a fundamentally shorter fuse.

France Made the Case in 2025

France's PACA region offers a case study that the Lancet data would have predicted.

Aedes albopictus has been established in southern France for years. PACA — which includes Marseille, Nice, and the Côte d'Azur — is not a recent invasion zone. It is a mature, densely established population. In 2025, PACA recorded 809 autochthonous chikungunya cases: an order-of-magnitude jump from any prior year, when counts were typically in single digits.

The virus arrived the way it almost always does in Europe: via travellers returning from endemic regions. The mosquito, present in density across the region, amplified it. And the recurrence clock — the 12 years that once separated successive outbreaks — was simply not in play. PACA had not waited 12 years. It had not waited one.

This is what the Lancet paper's "under one year between outbreaks" looks like on a regional level. Not a statistical abstraction, but a 809-case summer that arrived with little warning.

The Surveillance Assumption That Is Now Wrong

European vector surveillance was largely designed around the assumption of long lead times. Activating response plans when a cluster was confirmed, deploying larval source management in affected communes, alerting clinicians during peak season — these measures are reasonable when there are years between mosquito establishment and outbreak risk.

With a five-year median establishment-to-outbreak interval, that approach requires revision. Surveillance must be continuous and proactive from the moment the mosquito arrives, not reactive once cases appear. Clinicians in regions where Aedes albopictus has recently been confirmed need to consider chikungunya and dengue in the differential for fever and joint pain — not only in August, and not only in patients who have recently returned from the tropics.

France appears to have processed this logic operationally. ARS Île-de-France activated enhanced tiger mosquito surveillance on 1 May 2026, running through 30 November across all eight Île-de-France départements, with 435 egg traps including at three Paris airports. That is a near-year-round posture, calibrated to a world where the transmission window starts in spring and the next outbreak may be a single season away.

Where Europe Stands Now

Aedes albopictus is present in 83 of 96 French metropolitan départements. Italy's ISS reports the mosquito in virtually every region, with 133 imported dengue cases and 13 imported chikungunya cases already recorded by 30 April 2026 — and a domestic transmission window running through October.

Germany is at an earlier stage. The mosquito is established in specific districts of Wiesbaden — Südost, Kostheim, parts of Kastel — and has been documented in Munich since 2020. Local authorities still describe autochthonous transmission risk as "low", noting that no locally acquired dengue or chikungunya case has yet been confirmed. The Mückenatlas citizen-science portal continues to anchor national surveillance.

That "low risk now" framing is accurate. It is also, in the light of the Lancet analysis, a statement about the present rather than the near future. The mosquito's establishment in Wiesbaden is recent. The five-year countdown to outbreak risk may already be running.

Slovakia provides the most recent datapoint. A 2026 study published in Parasitology Research confirmed Aedes koreicus — a related invasive species from East Asia — by molecular evidence in Slovakia, with climate modelling identifying 15 additional European countries as suitable for permanent establishment. Aedes koreicus has demonstrated experimental vector competence for chikungunya. It is less widespread than albopictus, but its establishment trajectory in Central and Eastern Europe follows the same logic: arrival, then a compressing lag to first outbreak risk.

The Forward View

The Lancet Regional Health Europe finding pairs naturally with a separate result from the same body of European climate-health research: the Lancet Countdown on Health and Climate Change estimated a 297% increase in dengue outbreak risk across the continent, driven by changing Aedes albopictus suitability. The Regional Health Europe analysis provides the mechanistic explanation for why that risk is rising. It is not only that more places are now climatically suitable for the mosquito; it is that newly colonised places are reaching outbreak conditions faster than they used to.

ECDC's West Nile virus season opener for 2026 is expected once the first human cases are confirmed in June or July. The mosquito-borne disease surveillance calendar in Europe no longer has an off-season in the south.

For countries where Aedes albopictus established recently — Slovakia, Hungary, Slovenia, parts of Austria — the Lancet data suggest a meaningful probability of a first autochthonous dengue or chikungunya outbreak before 2030. That is not a distant projection. It is a near-term planning horizon.

The mosquito is not waiting.

What we know

Sources Cited

1. The Lancet Regional Health – Europe. Impact of climate and Aedes albopictus establishment on dengue and chikungunya outbreaks in Europe (late 2025; widely cited April–May 2026): https://www.sciencedirect.com/science/article/pii/S2542519625000592 (paywalled; key data via Mosticare GCS brief, 2026-05-13)
2. ARS Île-de-France. Tiger-mosquito surveillance activated 1 May 2026: https://www.iledefrance.ars.sante.fr/lutte-antivectorielle-lars-ile-de-france-lance-sa-campagne-de-surveillance-renforcee-partir-du-1er
3. Istituto Superiore di Sanità. Dengue and chikungunya surveillance update, 30 April 2026: https://www.epicentro.iss.it/febbre-dengue/aggiornamenti
4. Wiesbadenaktuell. Tiger mosquito seasonal update, March 2026: https://wiesbadenaktuell.de/2026/03/26/tigermuecken-saisonbeginn-jetzt-brutstaetten-pruefen-und-vorbeugen/
5. Parasitology Research. Aedes koreicus confirmed in Slovakia; 15 further EU countries climatically suitable (2026 online first): https://link.springer.com/article/10.1007/s00436-026-08628-y